Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: In vitro in vivo correlation

被引:202
|
作者
Fricker, G
Drewe, J
Huwyler, J
Gutmann, H
Beglinger, C
机构
[1] KANTONSSPITAL,DIV GASTROENTEROL,CH-4031 BASEL,SWITZERLAND
[2] KANTONSSPITAL,MED OUTPATIENT CLIN,CH-4031 BASEL,SWITZERLAND
[3] UNIV BASEL HOSP,DEPT ANAESTHESIA & RES,CH-4031 BASEL,SWITZERLAND
关键词
cyclosporin A; p-glycoprotein; Caco-2; cells; intestinal absorption; intubation study; local administration;
D O I
10.1111/j.1476-5381.1996.tb15612.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The interaction of cyclosporin A (CyA) with p-glycoprotein during intestinal uptake was investigated by a combination of in vitro experiments with human Caco-2 cells and an intubation study in healthy volunteers. 2 CyA uptake into the cells was not saturable and exhibited only a low temperature sensitivity, suggesting passive diffusion. When the permeation of CyA across Caco-2 monolayers from the apical to the basolateral side was determined, overall transport had an apparently saturable component up to a concentration of 1 mu M. At higher concentrations permeation increased over-proportionally. Calculation of the kinetic parameters of apical to basolateral permeation suggested a diffusional process with a K-D of 0.5 mu l min(-1) per filter, which was overlayed by an active system in basolateral to apical direction with a K-M of 3.8 mu M and a J(max) of 6.5 picomol min(-1) per filter. 3 CyA permeation was significantly higher when the drug was given from the basolateral side as compared to the permeation from the apical side. Apical to basolateral transport of CyA was increased in the presence of vinblastine, daunomcyin and a non-immunosuppressive CyA-derivative. All compounds inhibit p-glycoprotein-mediated transport processes. Basolateral to apical permeation of CyA showed a dose-dependent decrease in the presence of vinblastine. Permeation of daunomycin across Caco-2 cell monolayers was also higher from the basolateral to the apical side than vice versa. Basolateral to apical permeation was decreased in the presence of SDZ PSC 833 and cyclosporin A. 4 Western blot analysis of Caco-2 cells with the monoclonal antibody C219 confirmed the presence of p-glycoprotein in the used cell system. 5 When the absorption of CyA in the gastrointestinal (GI)-tract of healthy volunteers was determined, a remarkable decrease of the plasma AUC could be observed dependent on the location of absorption in the rank order stomach >jejunum/ileum > colon. The decrease in absorption exhibited a marked correlation (r=0.994) to the expression of mRNA for p-glycoprotein over the GI-tract (stomach<jejunum < colon). 6 All data provide evidence that CyA is a substrate of p-glycoprotein in the GI-tract, which might explain the local differences and the high variability in cyclosporin absorption found in vivo.
引用
收藏
页码:1841 / 1847
页数:7
相关论文
共 50 条
  • [1] Relevance of p-glycoprotein for the enteral absorption of Cyclosporin A. An in vitro in vivo correlation
    Fricker, G
    Drewe, J
    Beglinger, C
    GASTROENTEROLOGY, 1996, 110 (04) : A325 - A325
  • [2] In vitro-in vivo correlation in p-glycoprotein mediated transport in intestinal absorption
    del Amo, Eva M.
    Heikkinen, Aki T.
    Monkkonen, Jukka
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (2-3) : 200 - 211
  • [3] Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
    Cornaire, G
    Woodley, J
    Hermann, P
    Cloarec, A
    Arellano, U
    Houin, G
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 278 (01) : 119 - 131
  • [4] Limited role of P-glycoprotein in the intestinal absorption of cyclosporin A
    Lee, YJ
    Chung, SJ
    Shim, CK
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (04) : 760 - 763
  • [5] Relevance of P-glycoprotein for the transport of cyclosporin A across intestine, liver and kidney
    Fricker, G
    Drewe, J
    Miller, D
    HEPATOLOGY, 1997, 26 (04) : 13 - 13
  • [6] In vitro P-glycoprotein up-regulation by cyclosporin.
    Lian, AJ
    Gao, W
    Ito, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P27 - P27
  • [7] In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban
    Gnoth, Mark Jean
    Buetehorn, Ulf
    Muenster, Uwe
    Schwarz, Thomas
    Sandmann, Steffen
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (01): : 372 - 380
  • [8] In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system
    Feng, Bo
    Mills, Jessica B.
    Davidson, Ralph E.
    Mireles, Rouchelle J.
    Janiszewski, John S.
    Troutman, Matthew D.
    de Morais, Sonia M.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (02) : 268 - 275
  • [9] Molecular interactions of cyclosporin A with P-glycoprotein - Photolabeling with cyclosporin derivatives
    Demeule, M
    Wenger, RM
    Beliveau, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) : 6647 - 6652
  • [10] Interactions of cyclosporin with P-glycoprotein:: Photolabeling with cyclosporin-derivatives.
    Demeule, M
    Wenger, RM
    Béliveau, R
    FASEB JOURNAL, 1997, 11 (09): : A1253 - A1253